A synchronous medullary and papillary thyroid carcinoma

Authors

  • Oscar Varela-Cano Department of Head and Neck Surgery at Instituto Nacional de Cancerología, Ciudad de México, Mexico http://orcid.org/0000-0002-1862-4036
  • Zelik Luna-Peteuil Universitatea de Medicinâ și Farmacie Grigore T. Popa, Iași, Rumania
  • Kuauhyama Luna-Ortiz Department of Head and Neck Surgery at Instituto Nacional de Cancerología, Ciudad de México, Mexico

DOI:

https://doi.org/10.18203/issn.2454-5929.ijohns20220483

Keywords:

Synchronic papillary and medullary tumor, Cancer, Treatment

Abstract

The synchronous occurrence of medullary thyroid carcinoma (MTC) and papillary thyroid carcinoma (PTC) is rare (<1%). The medullary component determines the prognosis. A 31-year-old female with no relevant personal or family cancer history presented with swelling on the right side of the neck. A fine-needle aspiration biopsy was positive for MTC and PTC. Mass sequencing of 322 genes associated with cancer came back negative. The histopathological examination revealed synchronous MTC and PTC with thymic and bilateral lymph node metastasis. The patient underwent total thyroidectomy with bilateral radical neck dissection (II-V), central dissection, and mediastinal dissection including the thymus. The extent of surgery is determined by MTC and the analysis of RET and BRAF mutations. Post-operative treatment must include monitoring for specific markers (calcitonin and thyroglobulin, respectively, for MTC and PTC). Based on histopathological results and recurrent PTC, TSH suppression and iodine-131 therapy should be considered. Recurrent MTC must be treated with new targeted therapies.

References

Sipos JA, Mazzaferri EL. Thyroid cancer epidemiology and prognostic variables. Clin Oncol (R Coll Radiol) 2010;22:395-404.

Sippel RS, Kunnimalaiyaan M, Chen H. Current management of medullary thyroid cancer. Oncologist. 2008;13(5):539-47.

Fibbi B, Pinzani P, Salvianti F, Rossi M, Petrone L, De Feo ML et al. Synchronous occurrence of medullary and papillary carcinoma of the thyroid in a patient with cutaneous melanoma: determination of BRAFV600E in peripheral blood and tissues. Report of a case and review of the literature. Endocr Pathol. 2014;25:324-31.

Koudounarakis E, Karatzanis A, Chatzidakis A, Tzardi M, Velegrakis G. Synchronous Multifocal medullary and papillary thyroid microcarcinoma detected by elastography. Int J Surg Case Rep. 2014;5(1):5-7.

Tang PY, Khor LY, Takano A. Malays. Synchronous papillary thyroid carcinoma and medullary thyroid carcinoma-a pitfall waiting to happen. J Pathol. 2017;39(2):171-4.

Hellmann AR, Patel A, Śledziński M, Obołończyk Ł, Bieńkowski M, Mikaszewski B et al. Medullary thyroid carcinoma of unknown primary origin with synchronous finding of papillary thyroid carcinoma. Endokrynol Pol. 2020;71(2):200-1.

Cheung L, Howlett D, El Teraifi H, Kirkland P. Association of synchronous medullary and papillary thyroid carcinomas with primary hyperparathyroidism: first case report and literature review. J Laryngol Otol. 2014;128:565-8.

Roshini AP, Ramesh R, Rajalakshmi T. HATRICK-Synchronous Triple Primary Tumors of Thyroid. Indian J Surg Oncol. 2018;9:592-4.

Demandante CG, Troyer DA, Miles TP. Multiple primary malignant neoplasms: case report and a comprehensive review of the literature. Am J Clin Oncol. 2003;26:79-83.

Warren S, Gates O (1932) Multiple primary malignant tumors: a survey of the literature and a statistical study. Am J Cancer 16:1358–1414.

García MG, Torres JAP, Pedraza AG, Luna-Ortiz K, Ruiz-Garcia E, Vidal-Millan S et al. Extensive Medullary Thyroid Cancer: Aggressive Surgery with Mediastinal Dissection is Worthwhile? J Surgical Endocrinol. 2017;1(1):1-7

Wong RL, Kazaure HS, Roman SA, Sosa JA. Simultaneous medullary and differentiated thyroid carcer: a population-level analysis of an increasingly common entity. Ann Surg Oncol. 2012;19(8):2635-42.

Downloads

Published

2022-02-24

Issue

Section

Case Reports